EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Trained immunity agonists given to neonatal mice fail to protect against leptospiral infection in adulthood and may cause adverse effects

Mégane Fernandez iD, Frédérique Vernel-Pauillac iD, Tiffany Pezier iD, Sonia Lacroix-Lamandé iD, Catherine Werts iD

Innate Immunity · 2026

DOI: 10.1177/17534259261455983 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Innate Immunity, 2026. Verfasst von Mégane Fernandez und 4 weiteren Autor:innen. Beteiligte Einrichtung: INRAE, Université de Tours, UMR 1282 Infectiologie et Santé Publique, Laboratoire BiapI, Nouzilly, France. Hauptthemen laut MEDLINE: Nod2 Signaling Adaptor Protein, Leptospirosis, Leptospira. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: International coordination of research on infectious animal diseases, Institut Carnot Santé Animale France futur élevage, Institut Carnot Microbes Santé.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Trained immunity (TI) refers to a non-specific, long-lasting protective immune response that occurs following initial stimulation of the immune system and thought to be largely mediated by functional reprogramming of myeloid cells. TI has been demonstrated in BCG-vaccinated infants and can be induced in human cells and adult mice via agonists of pattern recognition receptors (PRR), such as β-glucan or MDP (a muropeptide that activates NOD2). However, its induction in neonates remains poorly understood. Previously, we demonstrated that the synthetic TLR2-NOD2 dual agonist CL429 enhances antimicrobial functions in adult mice and protects against subsequent infection with Leptospira interrogans , a zoonotic pathogen. We also demonstrated the immediate protective benefits of NOD2 stimulation in neonates against Cryptosporidium, a zoonotic pathogen that affects young animals in livestock herds. However, whether NOD2 agonists can induce TI in neonates and protect them at adulthood is unknown. Methods and Results Here, we investigated whether exposure of neonatal mice to PRR agonists (CL429, MDP or β-glucan), administered intraperitoneally at one week interval at 7/14 or 14/21 days of age, could enhance inflammatory cytokines production after ex vivo restimulation and confer long-term protection into adulthood. Surprisingly, none of the treatments enhanced ex vivo cytokine responses in adulthood after restimulation, nor did they confer protection against experimental leptospirosis. Instead, MDP-treated neonates exhibited 50% mortality following adult infection, revealing an unexpected detrimental effect. Conclusion These findings demonstrate that these PRR agonists fail to induce protective TI against Leptospira when administered to neonatal mice, challenging assumptions derived from adult models. Furthermore, our study reveals the risks of administering immunostimulants during the early stages of life, and highlights unanticipated and potentially harmful, PRR- and age-specific mechanisms of immune system modulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nod2 Signaling Adaptor ProteinLeptospirosisLeptospiraAnimalsMiceTrained ImmunityAnimals, NewbornHumansbeta-GlucansAcetylmuramyl-Alanyl-IsoglutamineMice, Inbred C57BLInnate Immunity RecognitionToll-Like Receptor 2Toll-Like Receptor AgonistsFemale

Stichwörter der Autor:innen

NOD2leptospirosismacrophagesneonatal micetrained immunity

Substanzen

Nod2 Signaling Adaptor Proteinbeta-GlucansAcetylmuramyl-Alanyl-IsoglutamineToll-Like Receptor 2Nod2 protein, mouseToll-Like Receptor Agonists

Autor:innen und Institutionen

  • INRAE, Université de Tours, UMR 1282 Infectiologie et Santé Publique, Laboratoire BiapI, Nouzilly, France.
  • Institut Pasteur, INSERM U1306, Unité de Biologie et Génétique de la Paroi Bactérienne, Paris, France.

ORCID-Profile: Mégane Fernandez, Frédérique Vernel-Pauillac, Tiffany Pezier, Sonia Lacroix-Lamandé, Catherine Werts

Förderung

  • International coordination of research on infectious animal diseases
  • Institut Carnot Santé Animale France futur élevage
  • Institut Carnot Microbes Santé

Zitieren

APA

Fernandez, M., Vernel-Pauillac, F., Pezier, T., Lacroix-Lamandé, S., & Werts, C. (2026). Trained immunity agonists given to neonatal mice fail to protect against leptospiral infection in adulthood and may cause adverse effects. Innate Immunity. https://doi.org/10.1177/17534259261455983

Vancouver

Fernandez M, Vernel-Pauillac F, Pezier T, Lacroix-Lamandé S, Werts C. Trained immunity agonists given to neonatal mice fail to protect against leptospiral infection in adulthood and may cause adverse effects. Innate Immunity. 2026. doi:10.1177/17534259261455983

BibTeX
@article{Fernandez2026,
  author = {Fernandez, Mégane and Vernel-Pauillac, Frédérique and Pezier, Tiffany and Lacroix-Lamandé, Sonia and Werts, Catherine},
  title = {Trained immunity agonists given to neonatal mice fail to protect against leptospiral infection in adulthood and may cause adverse effects},
  journal = {Innate Immunity},
  year = {2026},
  doi = {10.1177/17534259261455983}
}
Kostenlos starten →